• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia.

作者信息

McCoy J, Cadegiani F A, Wambier C G, Herrera S, Vaño-Galván S, Mesinkovska N A, Ramos P M, Shapiro J, Sinclair R, Tosti A, Goren A

机构信息

Applied Biology, Inc., Irvine, CA, USA.

Department of Clinical Endocrinology, Federal University of São Paulo Medical School, Sao Paulo, Brazil.

出版信息

J Eur Acad Dermatol Venereol. 2021 Apr;35(4):e243-e246. doi: 10.1111/jdv.17021. Epub 2020 Nov 22.

DOI:10.1111/jdv.17021
PMID:33135263
Abstract
摘要

相似文献

1
5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia.5-α还原酶抑制剂与雄激素性脱发男性新冠症状发作频率降低有关。
J Eur Acad Dermatol Venereol. 2021 Apr;35(4):e243-e246. doi: 10.1111/jdv.17021. Epub 2020 Nov 22.
2
Long-term efficacy and safety of the dual 5-alpha reductase blocker dutasteride on male androgenetic alopecia patients.双重5-α还原酶抑制剂度他雄胺对男性雄激素性脱发患者的长期疗效及安全性
J Dermatol. 2017 Dec;44(12):1408-1409. doi: 10.1111/1346-8138.13710. Epub 2016 Dec 18.
3
5α-Reductase inhibitors in men aged 50 years or older with androgenetic alopecia: A retrospective study.5α-还原酶抑制剂治疗50岁及以上男性雄激素性脱发的回顾性研究。
J Am Acad Dermatol. 2021 Jan;84(1):172-173. doi: 10.1016/j.jaad.2020.04.051. Epub 2020 Apr 19.
4
Guidelines for the management of androgenetic alopecia (2010).雄激素性脱发管理指南（2010年）
J Dermatol. 2012 Feb;39(2):113-20. doi: 10.1111/j.1346-8138.2011.01361.x. Epub 2011 Dec 16.
5
Photographic assessment improves adherence to recommended follow-up in patients with androgenetic alopecia and alopecia areata: A retrospective cohort study.摄影评估可提高雄激素性脱发和斑秃患者对推荐随访的依从性：一项回顾性队列研究。
Indian J Dermatol Venereol Leprol. 2019 Jul-Aug;85(4):431-433. doi: 10.4103/ijdvl.IJDVL_696_18.
6
Dutasteride in Androgenetic Alopecia: An Update.度他雄胺治疗雄激素性脱发：最新进展
Curr Clin Pharmacol. 2017;12(1):31-35. doi: 10.2174/1574884712666170310111125.
7
Long-term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia.度他雄胺治疗男性雄激素性脱发的长期安全性和有效性。
J Dermatol. 2016 Sep;43(9):1051-8. doi: 10.1111/1346-8138.13310. Epub 2016 Feb 19.
8
Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern?5α还原酶抑制剂疗法对雄激素性脱发男性的不良影响：是否需要担忧？
Actas Dermosifiliogr. 2016 Nov;107(9):709-711. doi: 10.1016/j.ad.2016.06.006. Epub 2016 Jul 18.
9
Hair Are the Rankings-5-α Reductase Inhibitors and Minoxidil in Male Androgenetic Alopecia.男性雄激素性脱发中5-α还原酶抑制剂和米诺地尔的排名情况
JAMA Dermatol. 2022 Mar 1;158(3):242-243. doi: 10.1001/jamadermatol.2021.5625.
10
Five-year efficacy of finasteride in 801 Japanese men with androgenetic alopecia.非那雄胺对801名日本雄激素性脱发男性的五年疗效
J Dermatol. 2015 Jul;42(7):735-8. doi: 10.1111/1346-8138.12890. Epub 2015 Apr 22.

引用本文的文献

1
The Experience of SARS-CoV-2 in Patients with Benign Prostatic Hyperplasia: Is There Any Correlation between Them?良性前列腺增生患者感染新型冠状病毒的经历：二者之间是否存在关联？
Maedica (Bucur). 2025 Mar;20(1):112-116. doi: 10.26574/maedica.2025.20.1.112.
2
TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target.跨膜丝氨酸蛋白酶2：新冠病毒感染中的关键宿主因子及潜在治疗靶点
Medeni Med J. 2025 Jun 26;26(4):101-109. doi: 10.4274/MMJ.galenos.2025.40460.
3
Antiandrogens as Therapies for COVID-19: A Systematic Review.
抗雄激素作为COVID-19的治疗方法：一项系统综述
Cancers (Basel). 2024 Jan 10;16(2):298. doi: 10.3390/cancers16020298.
4
Sex-Related Differences in the Pharmacological Response in SARS-CoV-2 Infection, Dyslipidemia, and Diabetes Mellitus: A Narrative Review.新型冠状病毒肺炎、血脂异常和糖尿病中药物反应的性别差异：一项叙述性综述
Pharmaceuticals (Basel). 2023 Jun 7;16(6):853. doi: 10.3390/ph16060853.
5
[Androgens and Parkinson's disease: the role in humans and in experiment].[雄激素与帕金森病：在人类及实验中的作用]
Probl Endokrinol (Mosk). 2022 Sep 4;68(6):146-156. doi: 10.14341/probl13148.
6
Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients.在 COVID-19 患者中使用抗雄激素作为治疗药物。
Viruses. 2022 Dec 7;14(12):2728. doi: 10.3390/v14122728.
7
SARS-CoV-2 vaccination in androgen sensitive phenotypes - A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients.雄激素敏感表型中的 SARS-CoV-2 疫苗接种 - 一项关于雄激素性脱发和良性前列腺增生患者 SARS-CoV-2 疫苗接种及其不良反应相关因素的研究。
Front Immunol. 2022 Sep 2;13:919958. doi: 10.3389/fimmu.2022.919958. eCollection 2022.
8
Impact of COVID-19 on male urogenital health: Success of vaccines.新冠疫情对男性泌尿生殖健康的影响：疫苗的成功。
Drug Discov Today. 2022 Oct;27(10):103327. doi: 10.1016/j.drudis.2022.07.012. Epub 2022 Jul 26.
9
Androgens and COVID-19.雄激素与 COVID-19。
J Cosmet Dermatol. 2022 Aug;21(8):3176-3180. doi: 10.1111/jocd.15090. Epub 2022 Jun 21.
10
Association between Mineralocorticoid Receptor Antagonist and Mortality in SARS-CoV-2 Patients: A Systematic Review and Meta-Analysis.盐皮质激素受体拮抗剂与新冠病毒患者死亡率之间的关联：一项系统评价与荟萃分析
Healthcare (Basel). 2022 Mar 30;10(4):645. doi: 10.3390/healthcare10040645.